By suppressing the expression of NE, the ratio of NE to A1AT can be further decreased along with the levels of the pro-inflammatory factors IL-8 and IL-1; this, in turn, can improve the therapeutic effects on PCOS. Here, CXCL8 is linked to polycystic ovary syndrome.